The New York Stock Exchange rules permit GSK to follow home country UK corporate governance practices instead of those that apply to US domestic issuers provided the company discloses any significant ways in which GSK's practices differ from those applying to US domestic issuers.
A table disclosing differences between GSK's domestic corporate governance practices and those applying to US domestic issuers is included in GSK's Annual Report on Form 20-F.